PRRT2 and glioma: Inhibition of MMP-2 in human glioma cell line U-87 results in a dramatic reduction in cell invasion [29], and induction of PKC activation in a D54 human glioblastoma cell line results in enhanced invasion through the activation of several metalloproteases including MMP-2 [30].